Chosa Oncology AB

At a glance

Most recent filing on October 21, 2026 — an open-market purchase by Peter Buhl on Oct 8, 2026.

We hold 3 visible filings, going back to December 2, 2016.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

All 3 shown

This page is free to read, and it stops after 3 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Peter Buhl Chief executive officer
29,825 SEKOpen-market buy
TradedOct 8, 2026FiledOct 21, 2026
Lars Höckenström Board member
55,982 SEKOpen-market buy
TradedDec 11, 2020FiledDec 11, 2020
Ventac Holdings Ltd. Closely associated: Board member or deputy board member, Board member or deputy board member
97,492 SEKOption exercise
TradedDec 2, 2016FiledDec 21, 2016